Mydecine to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th
June 23, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, June 23, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to...
Mydecine Unveils Artificial Intelligence Drug Discovery Program
June 16, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, June 16, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to...
Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms
June 08, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, June 08, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to...
Mydecine to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17th
June 03, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, June 03, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to...
Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms
May 25, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, May 25, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to...
Mydecine Provides Update on Spin-Out of U.S. Cannabis Assets
May 19, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, May 19, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed...
Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update
May 18, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, May 18, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to...
Mydecine to Participate in the Benzinga Global Small Cap Conference on May 13th
May 10, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, May 10, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to...
Mydecine Announces Partnership with LeadGen Labs
May 05, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, May 05, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to...
Mydecine Reports Full Year 2020 Financial Results and Provides Business Update
May 03, 2021 07:30 ET
|
Mydecine Innovations Group Inc.
Positioned as Leader in Emerging Psychedelic Therapeutics Market through Robust IP Portfolio, Novel Clinical Trials and Evolving Proprietary TechnologyStrengthened Balance Sheet with Approximately $30...